Why the study?
Does the BVS 5000 extracorporeal pulsatile assist device effectively bridge patients with severe shock or cardiomyopathy to recovery or transplantation?
Population
420 patients requiring temporary univentricular or biventricular support, including post-cardiotomy shock…
Design
Cohort
Follow-up
mean length of support 5.2 days
Authors
Loading...
May support BVS 5000 bridging across shock etiologies; extends observational data but leaves open need for randomized confirmation.
Does the BVS 5000 extracorporeal pulsatile assist device effectively bridge patients with severe shock or cardiomyopathy to recovery or transplantation?
The BVS 5000 provides effective short-term ventricular assistance, successfully bridging a significant proportion of patients with severe shock or cardiomyopathy to recovery or transplantation.
Gray et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: